| OR | 95% CI | P value |
---|---|---|---|
Patient characteristics | |||
 Age | 1.00 | (0.99, 1.01) | 0.89 |
 Female Sex | 1.02 | (0.70, 1.49) | 0.92 |
 Body Mass Index | 0.98 | (0.95, 1.01) | 0.16 |
 Heart Rate | 1.01 | (1.00, 1.02) | 0.07 |
 Systolic BP |  |  | 0.05 |
  Systolic BP < 90 | 0.68 | (0.37, 1.26) | 0.22 |
  90 ≤ Systolic BP < 125 | REF | REF | REF |
  Systolic BP ≥ 125 | 0.60 | (0.38, 0.93) | 0.02 |
Diastolic BP | 1.00 | (0.99, 1.01) | 0.86 |
Death during hospitalization | 1.36 | (0.84, 2.19) | 0.21 |
Fellow characteristics | |||
 Number of TTEs performed | 0.98 | (0.96, 1.01) | 0.15 |
 Study Year |  |  | 0.09 |
  2/2013–8/2013 | 1.32 | (0.71, 2.46) | 0.38 |
  9/2013–8/2014 | 0.62 | (0.34, 1.14) | 0.13 |
  9/2014–9/2015 | 0.79 | (0.45, 1.38) | 0.41 |
  9/2015–8/2016 | 1.25 | (0.65, 2.39) | 0.51 |
  9/2016–8/2017 | REF | REF | REF |
 Month of Fellowship (September to February vs. March to August) | 0.89 | (0.61, 1.31) | 0.56 |
 Time of TTE (nighttime vs. daytime) | 0.83 | (0.50, 1.38) | 0.47 |
TTE characteristics | |||
 Primary indication |  |  | 0.0003 |
  LV Function vs. Effusion | 2.40 | (1.53, 3.76) | 0.0002 |
  Effusion | REF | REF | REF |
  Other vs. Effusion | 1.23 | (0.70, 2.15) | 0.47 |
 Duration of study acquisition | 1.02 | (1.01, 1.03) | 0.003 |
 Location of TTE |  |  | 0.67 |
  ICU or PACU | 1.13 | (0.70, 1.84) | 0.61 |
  Catheterization or EP Lab | 0.74 | (0.20, 2.80) | 0.66 |
  Inpatient | 0.86 | (0.52, 1.43) | 0.57 |
  Emergency Department | REF | REF | REF |
 Post Procedure TTE | 0.58 | (0.36, 0.92) | 0.02 |
 Suboptimal Image Quality | 1.15 | (0.78, 1.69) | 0.48 |